Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Predictors of target lesion failure after treatment of left main, bifurcation, or chronic total occlusion lesions with ultrathin-strut drug-eluting coronary stents in the ULTRA registry.
de Filippo O, Bruno F, Pinxterhuis TH, Gąsior M, Perl L, Gaido L, Tuttolomondo D, Greco A, Verardi R, Lo Martire G, Iannaccone M, Leone A, Liccardo G, Caglioni S, González Ferreiro R, Rodinò G, Musumeci G, Patti G, Borzillo I, Tarantini G, Wańha W, Casella B, Ploumen EH, Pyka Ł, Kornowski R, Gagnor A, Piccolo R, Roubin SR, Capodanno D, Zocca P, Conrotto F, De Ferrari GM, von Birgelen C, D'Ascenzo F; ULTRA Collaborators. de Filippo O, et al. Among authors: zocca p. Catheter Cardiovasc Interv. 2023 Aug;102(2):221-232. doi: 10.1002/ccd.30696. Epub 2023 May 26. Catheter Cardiovasc Interv. 2023. PMID: 37232278
Very thin strut biodegradable polymer everolimus-eluting and sirolimus-eluting stents versus durable polymer zotarolimus-eluting stents in allcomers with coronary artery disease (BIO-RESORT): a three-arm, randomised, non-inferiority trial.
von Birgelen C, Kok MM, van der Heijden LC, Danse PW, Schotborgh CE, Scholte M, Gin RMTJ, Somi S, van Houwelingen KG, Stoel MG, de Man FHAF, Louwerenburg JHW, Hartmann M, Zocca P, Linssen GCM, van der Palen J, Doggen CJM, Löwik MM. von Birgelen C, et al. Among authors: zocca p. Lancet. 2016 Nov 26;388(10060):2607-2617. doi: 10.1016/S0140-6736(16)31920-1. Epub 2016 Oct 30. Lancet. 2016. PMID: 27806902 Clinical Trial.
Prediabetes and its impact on clinical outcome after coronary intervention in a broad patient population.
Kok MM, von Birgelen C, Sattar N, Zocca P, Löwik MM, Danse PW, Schotborgh CE, Scholte M, Hartmann M, Kant GD, Doelman C, Tjon Joe Gin M, Stoel MG, van Houwelingen G, Linssen GCM, IJzerman MJ, Doggen CJM, van der Heijden LC. Kok MM, et al. Among authors: zocca p. EuroIntervention. 2018 Oct 12;14(9):e1049-e1056. doi: 10.4244/EIJ-D-17-01067. EuroIntervention. 2018. PMID: 29313817 Free article.
Long-Term Outcome of Consecutive Patients With Previous Coronary Bypass Surgery, Treated With Newer-Generation Drug-Eluting Stents.
van der Heijden LC, Kok MM, Zocca P, Sen H, Löwik MM, Mariani S, de Man FHAF, Hartmann M, Stoel MG, van Houwelingen KG, Louwerenburg JHW, Linssen GCM, Doggen CJM, Grandjean JG, von Birgelen C. van der Heijden LC, et al. Among authors: zocca p. J Am Heart Assoc. 2018 Jan 30;7(3):e007212. doi: 10.1161/JAHA.117.007212. J Am Heart Assoc. 2018. PMID: 29382666 Free PMC article.
"Silent" Diabetes and Clinical Outcome After Treatment With Contemporary Drug-Eluting Stents: The BIO-RESORT Silent Diabetes Study.
von Birgelen C, Kok MM, Sattar N, Zocca P, Doelman C, Kant GD, Löwik MM, van der Heijden LC, Sen H, van Houwelingen KG, Stoel MG, Louwerenburg JHW, Hartmann M, de Man FHAF, Linssen GCM, Doggen CJM, Tandjung K. von Birgelen C, et al. Among authors: zocca p. JACC Cardiovasc Interv. 2018 Mar 12;11(5):448-459. doi: 10.1016/j.jcin.2017.10.038. Epub 2018 Feb 14. JACC Cardiovasc Interv. 2018. PMID: 29454724 Free article. Clinical Trial.
5-Year Outcome Following Randomized Treatment of All-Comers With Zotarolimus-Eluting Resolute Integrity and Everolimus-Eluting PROMUS Element Coronary Stents: Final Report of the DUTCH PEERS (TWENTE II) Trial.
Zocca P, Kok MM, Tandjung K, Danse PW, Jessurun GAJ, Hautvast RWM, van Houwelingen KG, Stoel MG, Schramm AR, Tjon Joe Gin RM, de Man FHAF, Hartmann M, Louwerenburg JHW, Linssen GCM, Löwik MM, Doggen CJM, von Birgelen C. Zocca P, et al. JACC Cardiovasc Interv. 2018 Mar 12;11(5):462-469. doi: 10.1016/j.jcin.2017.11.031. JACC Cardiovasc Interv. 2018. PMID: 29519378 Free article. Clinical Trial.
Bioresorbable Polymer-Coated Orsiro Versus Durable Polymer-Coated Resolute Onyx Stents (BIONYX): Rationale and design of the randomized TWENTE IV multicenter trial.
van der Heijden LC, Kok MM, Zocca P, Jessurun GAJ, Schotborgh CE, Roguin A, Benit E, Aminian A, Danse PW, Löwik MM, Linssen GCM, van der Palen J, Doggen CJM, von Birgelen C. van der Heijden LC, et al. Among authors: zocca p. Am Heart J. 2018 Apr;198:25-32. doi: 10.1016/j.ahj.2017.12.011. Epub 2017 Dec 21. Am Heart J. 2018. PMID: 29653644 Free article. Clinical Trial.
Two-year clinical outcome of all-comers treated with three highly dissimilar contemporary coronary drug-eluting stents in the randomised BIO-RESORT trial.
Kok MM, Zocca P, Buiten RA, Danse PW, Schotborgh CE, Scholte M, Hartmann M, Stoel MG, van Houwelingen G, Linssen GCM, Doggen CJM, von Birgelen C. Kok MM, et al. Among authors: zocca p. EuroIntervention. 2018 Oct 20;14(8):915-923. doi: 10.4244/EIJ-D-18-00336. EuroIntervention. 2018. PMID: 29790480 Free article. Clinical Trial.
39 results